[Diagnosis and treatment of Budd-Chiari syndrome]

Xiao-Ming Zhang1, Qing-Le Li

  • 1Department of Vascular Surgery, People's Hospital, Peking University, Beijing 100044, China. Rmxgwk@yahoo.com.cn

Insights

Budd-Chiari syndrome (BCS) etiology is unclear, with membranous BCS potentially arising from organized thrombus. Current surgical treatments are unsatisfactory, suggesting interventional therapy or resection for acquired membranous BCS.

Area of Science:

  • Vascular surgery
  • Hepatology
  • Interventional radiology

Context:

  • Budd-Chiari syndrome (BCS) etiology and pathology are not well understood.
  • Membranous BCS may originate from organized inferior vena cava (IVC) thrombus.
  • Current graft shunt operations for BCS show limited long-term effectiveness.

Purpose:

  • To clarify the etiology and pathology of Budd-Chiari syndrome.
  • To evaluate the effectiveness of current treatments for BCS.
  • To propose alternative therapeutic strategies for membranous BCS.

Summary:

  • The origin of membranes in membranous BCS is hypothesized to be from absorbed and organized IVC thrombus.
  • Hepatic vein obstruction in BCS is distinct from IVC stenosis caused by hepatomegaly.
  • Membranous BCS is considered an acquired condition.

Impact:

  • Highlights the need for further research into BCS pathogenesis.
  • Suggests interventional therapy or surgical resection as superior treatment options.
  • Reclassifies IVC stenosis due to hepatomegaly, differentiating it from BCS.